Hakan Parlakpinar (Hakan Parlakpınar)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Topics

Pulmonary Arterial Hypertension

Top Venues

Heart failure reviews

Fundamental & clinical pharmacology

Cardiovascular toxicology

Cell biochemistry and function

This page only lists publications with an associated author ORCID identifier.

Publications

Seyhan Ayik, Mehmet Gunata, Onural Özhan, Azibe Yıldız, Nigar Vardi, Emre Sonmez, Necip Ermis, Nilay Ates Ozsoy, Ertugrul Kilic, Samir Abbas Ali Noma, Ahmet Ulu, Seyfullah Taha Inan, Haci Ahmet Acet, Hakan Parlakpinar
Alamandin and especially melatonin attenuate pulmonary arterial hypertension induced by monocrotalin. Fundamental & clinical pharmacology (2024)
Necip Ermis, Zeynep Ulutaş, Onural Özhan, Azibe Yıldız, Nigar Vardi, Cemil Çolak, Hakan Parlakpinar
Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure. Biotechnic & histochemistry : official publication of the Biological Stain Commission (2023)
Mehmet Gunata, Hakan Parlakpinar
Experimental heart failure models in small animals. Heart failure reviews 28 (2) (2022)
Mehmet Gunata, Hakan Parlakpinar
Experimental heart failure models in small animals. Heart failure reviews 28 (2) (2022)
Ahmet Sedat Dündar, Mucahit Oruç, Osman Celbiş, Emine Türkmen Şamdancı, Ayse Nur Akatlı, Hasan Okumuş, Çağatay Taşkapan, Onural Özhan, Hakan Parlakpinar
An experimental rat model of electric shock injury with isolated electric shock and water conduction: the histopathological changes on the skin and internal organs and the effect on biochemical parameters. International journal of legal medicine (2022)
Sevgi Balcioglu, Samir Abbas Ali Noma, Ahmet Ulu, Merve Goksin Karaaslan-Tunc, Onural Özhan, Suleyman Koytepe, Hakan Parlakpinar, Nigar Vardi, Mehmet Cengiz Colak, Burhan Ateş
Fast Curing Multifunctional Tissue Adhesives of Sericin-Based Polyurethane-Acrylates for Sternal Closure. ACS applied materials & interfaces 14 (37) (2022)
Mehmet Gunata, Hakan Parlakpinar
Experimental heart failure models in small animals. Heart failure reviews (2022)
Lokman Hekim Tanriverdi, Onural Özhan, Ahmet Ulu, Azibe Yıldız, Burhan Ateş, Nigar Vardı, Hacı Ahmet Acet, Hakan Parlakpinar
Activation of the Mas receptors by AVE0991 and MrgD receptor using alamandine to limit the deleterious effects of Ang II-induced hypertension. Fundamental & clinical pharmacology (2022)
Mehmet Gunata, Hakan Parlakpinar
Experimental heart failure models in small animals. Heart failure reviews 28 (2) (2022)
Mehmet Gunata, Hakan Parlakpinar
Experimental heart failure models in small animals. Heart failure reviews 28 (2) (2022)
Azibe Yıldız, Nigar Vardi, Hakan Parlakpinar, Burhan Ateş, Neriman Çolakoğlu
Effects of Low- and High-Dose Valproic Acid and Lamotrigine on the Heart in Female Rats. Cardiovascular toxicology 22 (4) (2022)
Lokman Hekim Tanriverdi, Ahmet Sarici, Mehmet Ali Erkurt, Hakan Parlakpinar
The efficacy of voxelotor, 900 mg in patients with sickle cell anaemia: A meta-analysis of the randomised controlled trials. International journal of clinical practice 75 (6) (2021)
Hakan Parlakpinar, Mehmet Gunata
Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs. Immunopharmacology and immunotoxicology 43 (6) (2021)
Hilal Ermis, Hakan Parlakpinar, Hulya Elbe, Nigar Vardi, Alaaddin Polat, Gazi Gulbas
Effects of varenicline on lung tissue in the animal model. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 46 (2) (2020)
Hakan Parlakpinar, Onural Özhan, Necip Ermis, Nigar Vardi, Yilmaz Cigremis, Lokman Hekim Tanriverdi, Cemil Colak, Ahmet Acet
Acute and Subacute Effects of Low Versus High Doses of Standardized Panax ginseng Extract on the Heart: An Experimental Study. Cardiovascular toxicology 19 (4) (2020)
Hakan Parlakpinar, Seyhan Ayik, Haci Ahmet Acet
Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin. Fundamental & clinical pharmacology 35 (1) (2020)
Mehmet Gunata, Hakan Parlakpinar
A review of myocardial ischaemia/reperfusion injury: Pathophysiology, experimental models, biomarkers, genetics and pharmacological treatment. Cell biochemistry and function 39 (2) (2020)
Onural Özhan, Hakan Parlakpinar, Haci Ahmet Acet
Comparison of the effects of losartan, captopril, angiotensin II type 2 receptor agonist compound 21, and MAS receptor agonist AVE 0991 on myocardial ischemia-reperfusion necrosis in rats. Fundamental & clinical pharmacology 35 (4) (2020)
Hakan Parlakpinar, Mehmet Gunata
SARS-COV-2 (COVID-19): Cellular and biochemical properties and pharmacological insights into new therapeutic developments. Cell biochemistry and function 39 (1) (2020)
Ferhat Kalkan, Hakan Parlakpinar, Olcay M Disli, Lokman Hekim Tanriverdi, Onural Ozhan, Alaaddin Polat, Aslı Cetin, Nigar Vardi, Yılmaz O Otlu, Ahmet Acet
Protective and therapeutic effects of dexpanthenol on isoproterenol-induced cardiac damage in rats. Journal of cellular biochemistry 119 (9) (2018)